The Clorox Company (NYSE:CLX) Shares Sold by Northwestern Mutual Wealth Management Co.

Northwestern Mutual Wealth Management Co. decreased its position in The Clorox Company (NYSE:CLX) by 5.8% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,124 shares of the company’s stock after selling 689 shares during the quarter. Northwestern Mutual Wealth Management Co.’s holdings in Clorox were worth $1,518,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the company. Van ECK Associates Corp increased its stake in Clorox by 1,715.5% during the 2nd quarter. Van ECK Associates Corp now owns 1,461,207 shares of the company’s stock worth $199,411,000 after buying an additional 1,380,724 shares during the period. Point72 Asset Management L.P. acquired a new position in shares of Clorox in the fourth quarter worth about $144,844,000. Nuance Investments LLC boosted its holdings in Clorox by 150.6% in the second quarter. Nuance Investments LLC now owns 1,597,674 shares of the company’s stock valued at $218,035,000 after purchasing an additional 960,094 shares during the last quarter. Parsifal Capital Management LP acquired a new stake in Clorox during the 4th quarter valued at approximately $128,245,000. Finally, Confluence Investment Management LLC purchased a new stake in Clorox during the 1st quarter worth approximately $135,630,000. 78.53% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Clorox

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the sale, the executive vice president now owns 13,471 shares of the company’s stock, valued at $2,229,719.92. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.51% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have recently weighed in on CLX shares. Jefferies Financial Group raised shares of Clorox from a “hold” rating to a “buy” rating and raised their price target for the stock from $174.00 to $187.00 in a research report on Tuesday, October 1st. Citigroup boosted their target price on shares of Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a research report on Friday, September 6th. DA Davidson reaffirmed a “neutral” rating and set a $153.00 price target on shares of Clorox in a research report on Friday, September 6th. JPMorgan Chase & Co. lowered their price objective on Clorox from $150.00 to $148.00 and set a “neutral” rating for the company in a report on Friday, August 2nd. Finally, BNP Paribas upgraded Clorox to a “strong sell” rating in a research note on Friday, September 6th. Six investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat, Clorox currently has a consensus rating of “Hold” and a consensus target price of $146.13.

Clorox Price Performance

Shares of CLX opened at $161.57 on Friday. The Clorox Company has a 12 month low of $114.68 and a 12 month high of $169.09. The company has a debt-to-equity ratio of 5.04, a current ratio of 1.03 and a quick ratio of 0.63. The stock has a fifty day moving average price of $154.91 and a 200 day moving average price of $144.43. The company has a market cap of $20.07 billion, a P/E ratio of 83.72, a PEG ratio of 3.31 and a beta of 0.41.

Clorox (NYSE:CLX) last released its quarterly earnings results on Thursday, August 1st. The company reported $1.82 EPS for the quarter, topping the consensus estimate of $1.54 by $0.28. The business had revenue of $1.90 billion during the quarter, compared to analyst estimates of $1.97 billion. Clorox had a net margin of 3.95% and a return on equity of 281.12%. On average, research analysts forecast that The Clorox Company will post 6.63 earnings per share for the current year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be issued a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.02%. Clorox’s dividend payout ratio (DPR) is presently 252.85%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.